• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-PFO-025
Device Problem Unintended Movement (3026)
Patient Problem Regurgitation (2259)
Event Date 12/13/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).The results of the investigation are inconclusive since the device was not returned for analysis.Our investigation was limited to the review of the device history record, which showed that each manufacturing and inspection operation was performed and indicated complete in accordance with sjm specifications and procedures.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
On (b)(6) 2016, the amplatzer pfo occluder (pfo) was implanted in the patient's large pfo with an aneurysmal septum.The pfo was positioned and several stability tests were performed before release.The patient was discharged to home on the same day.Hemostasis had been achieved; however, after leaving the hospital the patient travelled 2-3 hours home.That evening the patient went to another hospital and was treated for a gi bleed.There was concern by the consultants that the pfo device embolized secondary to a valsalva maneuver at this time.On (b)(6) 2016, the patient presented for a follow-up toe post pfo closure.The pfo was difficult to image, but a left to right stunt was revealed.A chest x-ray confirmed the pfo had embolized in the patient's pa.The patient was placed on apixobahn.On (b)(6) 2016, surgery was performed to remove the pfo and close the patient's pfo.The patient was reported to be in stable condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key6257442
MDR Text Key64965194
Report Number2135147-2017-00008
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/17/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Model Number9-PFO-025
Device Catalogue Number9-PFO-025
Device Lot Number5148783
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/20/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/06/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age44 YR
-
-